Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2010
10/19/2010US7816350 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout
10/19/2010US7816334 Nucleic acid construct and nucleic acid expression vectors directing expression of a fusion protein consisting of a disease peptide antigen and a first domain of FrC of tetanus toxin; vaccines
10/19/2010US7816333 nucleosides such as 3',5'-di-O-Benzyl-2'-O,4'-C-ethylene-4-N-benzoylcytidine for treatment of pain, psoriasis, inflammatory disorders, infectious skin disease, skin cancer, Lyme disease, influenza virus, cytomegalovirus, herpes virus, herpes simplex virus, papilloma virus, Epstein Barr virus or HIV
10/19/2010US7816319 Methods and products for manipulating uncoupling protein expression
10/19/2010US7816317 Tripeptide prodrug compounds
10/19/2010US7815921 Using patient's leukocyte concentration after incubation with colony stimulation factor as evaluative tool in predicting susceptibility to infection, bone marrow and autoimmune diseases after chemotherapeutic treatments
10/19/2010US7815920 Method of preparing an antigen-containing formulation
10/19/2010US7815915 Mixture of human papillomavirus virus-like particles
10/19/2010US7815910 Antigen and adjuvant of immunity, a surfactant, or a mixture of surfactants, having an overall HLB number of between 5 and 15; for application orally, nasally, rectally, or vaginally
10/19/2010CA2469346C Substituted 2-pyrrolidin-2-yl-1h-indole derivatives for treatment of migraine
10/19/2010CA2468314C The use of water-soluble lamarin in the treatment of cancer
10/19/2010CA2458699C Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
10/19/2010CA2451422C Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
10/19/2010CA2448089C Thiolalkyl benzoic acid derivatives
10/19/2010CA2439791C Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases
10/19/2010CA2416512C Enhancement of the action of anti-infective agents
10/19/2010CA2415577C Use of cox-2 inhibitors for preventing immunodeficiency
10/19/2010CA2411590C Glycopeptide phosphonate derivatives
10/19/2010CA2399434C Isolation and transplantation of retinal stem cells
10/19/2010CA2366896C Method for the purification, recovery, and sporulation of cysts and oocysts
10/19/2010CA2337618C Chicken anaemia viruses of low pathogenicity
10/19/2010CA2307842C Hyaluronan synthase gene and uses thereof
10/19/2010CA2177249C Abundant extracellular products and methods for their production and use
10/19/2010CA2165393C Anti-bordetella acellular vaccine
10/14/2010WO2010118424A2 Papillomavirus-like particles (vlp) as broad spectrum human papillomavirus (hpv) vaccines
10/14/2010WO2010118367A2 Antiviral pyrimidines
10/14/2010WO2010118078A1 Macrocyclic serine protease inhibitors
10/14/2010WO2010117977A1 Hepatitis c virus inhibitors
10/14/2010WO2010117974A2 Hiv-resistant stem cells and uses thereof
10/14/2010WO2010117939A1 Hcv inhibitor and therapeutic agent combinations
10/14/2010WO2010117936A1 Combinations of a hcv inhibitor such as bicyclic pyrrole derivatives and a therapeutic agent
10/14/2010WO2010117935A1 Compounds and methods for antiviral treatment
10/14/2010WO2010117932A1 Indole derivatives and methods for antiviral treatment
10/14/2010WO2010117704A1 Hepatitis c virus inhibitors
10/14/2010WO2010117635A1 Hepatitis c virus inhibitors
10/14/2010WO2010117296A1 Agent for preventing influenza and acute respiratory diseases
10/14/2010WO2010117287A2 A virus-like particle vector for delivery of pharmaceutical agents, a process for the manufacture thereof, its uses and a pharmaceutical composition.
10/14/2010WO2010116740A1 Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action
10/14/2010WO2010116375A1 Isolated peptides for regulating apoptosis
10/14/2010WO2010116337A1 2-hydroxyethyl-1h-quinolin-2-one derivatives and their azaisosteric analogues with antibacterial activity
10/14/2010WO2010116336A1 Uses of red yeast rice in treating dengue virus infection
10/14/2010WO2010116248A1 Organic compounds and their uses
10/14/2010WO2010116048A1 Plant composition for the treatment or prevention of viral blood-borne diseases such as diseases caused by the human immunodeficiency virus (hiv) or hepatitis c
10/14/2010WO2010116016A1 Use of peptides of the e1 protein of the hepatitis g virus in order to inhibit the activity of the hiv virus
10/14/2010WO2010116015A1 Use of peptides of the e2 protein of the hepatitis g virus in order to inhibit the activity of the hiv virus
10/14/2010WO2010115981A1 7-azadispiro [3.0.4.1] decane-8-carboxamides as hepatitis c virus inhibitors
10/14/2010WO2010115901A1 Pyrrolopyridine therapeutic compounds
10/14/2010WO2010115836A1 Substituted piperidines as ccr3 antagonists
10/14/2010WO2010115278A1 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
10/14/2010WO2010115264A1 Inhibitors of hiv replication
10/14/2010WO2010068760A3 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
10/14/2010WO2010065905A3 Compounds having antiparasitic or anti-infectious activity
10/14/2010WO2010062369A3 Methods and compositions for inhibiting clostridium difficile spore germination and outgrowth
10/14/2010WO2010042548A9 Methods of treating inflammation
10/14/2010WO2010041218A3 Oxazolidinyl antibiotics
10/14/2010US20100263061 Properdin Modulation of Alternative Pathway and Uses Thereof
10/14/2010US20100261779 Phosphate-Modified Oligonucleotide Analogs with Enhanced Immunostimulatory Activity
10/14/2010US20100261766 Phenyl-Oxetanyl-Derivatives
10/14/2010US20100261763 Antibacterial agents and methods of use thereof
10/14/2010US20100261751 Method for determining one of the two human immunodeficiency virus (hiv) integrase enzymatic activities
10/14/2010US20100261731 Method for Treating a Disease, Disorder or Adverse Effect Caused by an Elevated Serum Concentration of an UGT1A1 Substrate
10/14/2010US20100261722 Hiv inhibiting 5, 6-substituted pyrimidines
10/14/2010US20100261719 Chemical compounds
10/14/2010US20100261714 Inhibitors of hiv replication
10/14/2010US20100261709 Pyridazinone derivatives as parp inhibitors
10/14/2010US20100261703 Salt and crystalline forms thereof of a drug
10/14/2010US20100261700 Beta-lactamase inhibitors
10/14/2010US20100261695 Treatment of onychomycosis and related compositions
10/14/2010US20100261688 Stabilization of oily suspensions comprising hydrophobic silicas
10/14/2010US20100261687 Substituted piperidines as ccr3 antagonists
10/14/2010US20100261673 Antibacterial compounds and methods of using same
10/14/2010US20100261667 3-ß-D-RIBOFURANOSYLTHIAZOLO[4-5-d]PYRIMIDINE NUCLEOSIDES AND USES THEREOF
10/14/2010US20100261641 Spiro-piperidine compounds and medicinal use thereof
10/14/2010US20100261640 Soluble and membrane anchored forms of lassa virus subunit proteins
10/14/2010US20100261639 Triazole-based aminoglycoside-peptide conjugates and methods of use
10/14/2010US20100261638 Lantibiotic-based compounds having antimicrobial activity
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
10/14/2010US20100261271 Regulation of endogenous gene expression in cells using zinc finger proteins
10/14/2010US20100260875 Natural composition for curing hepatitis-b, methods for making the same and pharmaceutical formulations thereof
10/14/2010US20100260870 Method and preparations for treating infection-allergic diseases
10/14/2010US20100260865 Viricidal composition
10/14/2010US20100260829 Sustained Release of Antiinfectives
10/14/2010US20100260817 Polyamine Derivatives
10/14/2010US20100260808 Method for Increasing Immunoreactivity
10/14/2010US20100260803 Bordetella Parapertussis Whole-Cell Vaccine Composition
10/14/2010US20100260802 RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE
10/14/2010US20100260801 Polysaccharide vaccine for staphylococcal infections
10/14/2010US20100260800 AVV Vectors and Methods
10/14/2010US20100260799 SIMIAN SUBFAMILY C ADENOVIRUSES SAdV-40, -31, AND -34 AND USES THEREOF
10/14/2010US20100260798 Method for purifying the rabies virus
10/14/2010US20100260797 Influenza composition
10/14/2010US20100260795 Carrier Particle for a Microorganism or Subunit Thereof, Pharmaceutical Composition Comprising such Particles, Method for Preparation of this Composition and Its Use in the Treatment of Animals
10/14/2010US20100260794 Live attenuated salmonella vaccine
10/14/2010US20100260793 Defensin-antigen fusion proteins
10/14/2010US20100260792 Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres
10/14/2010US20100260790 S. Pneumoniae Antigens
10/14/2010US20100260789 Products specific to pathogenic strains and their use as vaccines and in immunotherapy
10/14/2010US20100260778 Small-molecule botulinum toxin inhibitors
10/14/2010US20100260777 Treatment and/or prevention of sepsis using an enteral composition
10/14/2010US20100260773 Antibody molecules having binding specificity for human il-13
1 ... 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 ... 1798